and sICH patients. In univariate analysis, high systolic BPV was associated with sICH (p = 0.03). A logistic regression model to predict ICH only found early CT findings (OR = 2.74, 95% CI = 1.47-5.11, p ! 0.01) as independently associated with ICH. Poor 3-month outcome was independently predicted by age (OR = 0.96, 95% CI = 0.94-0.97, p ! 0.001), NI-HSS on admission (OR = 0.84, 95% CI = 0.80-0.87, p ! 0.001), ICH (OR = 0.29, 95% CI = 0.13-0.66, p ! 0.01) and high systolic BPV (OR = 1.68, 95% CI = 1.05-2.69, p ! 0.05). Conclusions: We demonstrate that high BPV in patients receiving IVT leads to poor outcome but does not increase the risk of ICH/sICH.
Introduction
After intravenous thrombolysis (IVT) in acute stroke, the development of hemorrhagic transformation (HT) and especially symptomatic intracerebral hemorrhage (sICH) are some of the most feared adverse events. Several conditions are suggested to enhance the risk of HT/ sICH, including among others age [1] , stroke severity presented by the National Institute of Health Stroke Scale (NIHSS) [2] , congestive heart failure [1] , early infarct signs [1, 3] , platelet count [4] , serum glucose and diabetes [5] , antithrombotics [1] , time to treatment [6] and elevated systolic blood pressure (BP) [1, 7] . Blood pressure variability (BPV) -the variation of BP with time -is presumed to be a strong and independent predictor of stroke in general, potentially more powerful than the absolute BP levels [8] . In addition, BPV was linked to stroke and development of HT and was demonstrated to be independently associated with outcome and with development of HT during the first 7 days after IVT [9, 10] . Furthermore, BPV seems to contribute to growth of diffusion-weighted imaging lesions and deterioration of clinical course after IVT [11] . Most recently, a study demonstrated that BPV enhances the risk of HT within 72 h after acute cerebral infarction independently of treatment with IVT [12] . Besides, BPV was shown to influence short-term outcome after stroke by increasing the rate of death and neurologic deterioration at day 10 after stroke [13] .
In the present study, we aimed to investigate the effects of BPV on development of any intracerebral hemorrhage (ICH) and sICH and 3-month outcome after IVT in acute ischemic stroke.
Methods
From our consecutive local stroke database, we extracted data for all prospectively documented patients treated with recombinant tissue plasminogen activator intravenously in the years 2007-2009. Local standard operating procedures recommend BP to be measured using an automatic monitoring system (Infinity Delta, Draeger Medical Systems Inc.) before IVT, every 15 min for the first 2 h after the start of IVT and at least hourly thereafter until the follow-up imaging examination. Exceptions from this rule are patients with BP levels above 185/90 mm Hg where these intervals are shortened. In case of elevated BP before and after IVT, treatment with antihypertensives -usually urapidil (5-50 mg i.v.) -is recommended in the standard operating procedures. BP levels are noted in the patient's file, which is electronically archived after discharge. These documents formed the basis for our retrospective analysis of the BP levels. Baseline and demographic characteristics, cardiovascular risk factors, time intervals, admission and follow-up imaging scans, and stroke severity using the NIHSS were prospectively collected. All patients were reassessed after 3 months either during an outpatient visit or by a telephone interview using the modified Rankin Scale by an investigator not blinded to the IVT treatment but unaware of BP levels and BPV. A favorable outcome after 3 months was defined as a modified Rankin Scale score of less than 2.
Early infarct signs were defined as parenchymal hypoattenuation or loss of gray-white differentiation in the cortical ribbon or the basal ganglia and/or mass effect in the baseline CT due to an ischemic lesion.
A follow-up imaging scan was performed 20-36 h after IVT or immediately after clinical deterioration was diagnosed. If clinical deterioration developed later, another scan was carried out; thus, later clinically relevant bleedings were also detected and collected. New hyperdense brain lesions were counted as ICH, irrespective of the clinical consequences. According to the definition in the ECASS trials [14] , the ICHs were grouped according to morphological appearance. HT was defined as a petechial infarction, whereas HT1 presents small and HT2 more confluent petechiae. Parenchymal hematoma (PH) contributes to a hemorrhage with mass effect. PH1 was defined as hemorrhage ^30% of the infarcted area with mild space occupying effect and PH2 130% of the infarcted area with significant space occupying effect, or clot remote from infarcted area. sICH was defined according to the ECASS 2 definition (detection of blood plus NIHSS worsening by 4 or more points or leading to death).
The BP values were analyzed until follow-up imaging scan and are described as follows: mean, maximum, minimum, standard deviation (SD) and difference between maximum and minimum. To represent BPV of an individual, we used successive variation (SV) and maximum SV [9] . SV is calculated as the square root of the average squared difference between two successive BP measurements using the following equation:
In contrast with the widely known sample SD, the SV addresses the time sequence of measurements. Patients were grouped in high ( 1 median) and low ( ^ median) systolic and diastolic BPV.
Due to the retrospective character of this study, the lack of treatment influence, and data being collected as part of national and international quality control programs, we did not apply for the vote of an ethics committee.
Statistical Analysis
Normally distributed data are present as mean and SD and nonnormally distributed data as median and interquartile range or counts and percentages, respectively. Comparison between ICH-negative, ICH-positive and sICH according to baseline characteristics, risk factors for ICH and BP values as well as univariate analysis of outcome parameters were conducted with oneway ANOVA. All parameters showing significance in the univariate analysis were tested in a multivariate logistic regression model to explore predictors for ICH and main outcome parameters. Due to the possible colinearity of tested variables, we applied a stepwise logistic regression model. The results were considered statistically significant when p ! 0.05. For all statistical testing, we used the Statistical Package for Social Sciences (SPSS Inc., v. 16.0 for Windows).
Results
Among 427 patients treated with IVT in the years 2007-2009, 51 (11.9%) patients had any ICH and 10 (2.3%) patients suffered from sICH. We observed HT1 in 14 (3.3%), HT2 in 10 (2.3%), PH1 in 16 (3.7%), PH2 in 10 (2.3%) and subarachnoid hemorrhage in 1 (0.3%) of our patients. Table 1 shows baseline characteristics and table 2 shows risk factors for any ICH and sICH and radiological ICH types. The median frequency (interquartile range) of BP measurements until follow-up imaging scan was 21.5 (9) in ICH-negative, 20 (9) in ICH-positive and 12.6 (15) in sICH patients.
Systolic and diastolic BP profiles, including mean, maximum, minimum, SD, difference between maximum and minimum, SV and maximum SV did not differ between ICH-negative, ICH-positive and sICH patients ( table 3 ), with the exception of the minimum diastolic BP, showing significantly higher levels in ICH-positive than ICH-negative patients (p = 0.02).
In univariate analysis of systolic and diastolic BP, each of them divided into groups of high and low BPV, we found an association between high systolic BPV and occurrence of sICH (p = 0.03). With regard to the 3-month outcome, low systolic BPV was strongly related to independency (p ! 0.001) and there was a trend of high systolic BPV being related to mortality (p = 0.07). Mortality was more frequent in patients with high diastolic BPV (p = 0.04) and independency tended to appear more often in patients with low diastolic BPV (p = 0.07) ( table 4 ) .
In a stepwise logistic regression model including all parameters showing a significant difference between ICH-positive and ICH-negative patients in univariate analysis (NIHSS on admission, early CT findings, platelets, atrial fibrillation), neither systolic nor diastolic BPV predicts ICH. Only early CT findings remain an independent risk factor for ICH in our patients (OR = 2.74, 95% CI = 1.47-5.11, p ! 0.01) ( table 5 ). Because early infarct signs were the only parameter which was associated with sICH in univariate analysis, no multivariate analysis was ( table 6 ) .
Discussion
In this retrospective analysis of 427 consecutive patients treated with IVT, we report BP measurements until follow-up imaging scan in a range of 21 measurements per patient. First of all, we found no difference between BP levels in ICH-negative and ICH-positive patients. In contrast to a recently published study, we also found no difference in BPV between ICH-negative and ICH-posi- 3 Comparison between ICH negative and sICH. 4 Thirty-three patients were treated based on MRI. tive patients and therefore we cannot confirm a relation between BPV and development of ICH or sICH which was suggested in this study [12] . However, in agreement with Yong et al. [9] , we report systolic BPV as a strong and independent predictor of the 3-month outcome after acute stroke and IVT. There are some differences between our study and the study by Ko et al. [12] which might partially explain these discrepancies: the number of patients who received IVT was nearly three times higher in our study (427 vs. 158), although the absolute number of patients was smaller. We exclusively report about patients receiving IVT; this might explain why the absolute BP levels are lower due to a more aggressive treatment of elevated BP levels in those patients (e.g. maximum systolic BP in ICH-positive patients 188.6 vs. 180.8 mm Hg, maximum diastolic BP in ICH-negative patients 113.7 vs. 99.4 mm Hg). However, this does not explain why SD values of systolic and diastolic BP are remarkably similar, i.e. 16.5 and 11.2 mm Hg in the study by Ko et al. [12] and 16.7 and 11.8 mm Hg in ours. We observed BP values until control imaging scan -in a range of 24 h after admission -whereas Ko et al. [12] obtained BP measurements during the first 72 h. During this period, our median frequency of BP measurements was 21 as compared with 18 and thus we monitored more BP levels in a shorter interval. Finally, in contrast to Ko et al. [12] , we differentiate between radiologic types of ICH and especially between asymptomatic and symptomatic ones, because whether or not asymptomatic ICH is of any clinical relevance is still doubtful [15] .
Pathophysiological considerations concerning the impact of BPV include that, on the one hand, a rapid increase in BP could lead to rupture of blood vessels and therefore to HT/ICH, and on the other hand a sudden decrease might cause a shortage of cerebral perfusion and thus could lead to a clinically relevant deterioration due to reduced perfusion of the penumbra. All in all, it seems that low BPV is beneficial for longterm outcome and to counteract high BPV might be a target to improve outcome in IVT-treated stroke patients. But whether BPV leads to development of ICH/sICH is still doubtful in our opinion, and thus the way BPV influences the outcome remains unclear.
As data from larger trials are still lacking due to the limited number of reported BP values, more data from single centers should be published to enable the performance of a meta-analysis in the future.
Conclusion
We demonstrate that high BPV in patients receiving IVT leads to poor outcome but does not increase the risk of ICH/sICH.
